Anti-CELA1/ ELA1 functional antibody

Anti-CELA1/ ELA1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CELA1/CELA1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T22839-Ab-1/ GM-Tg-hg-T22839-Ab-2Anti-Human CELA1 monoclonal antibodyHuman
GM-Tg-rg-T22839-Ab-1/ GM-Tg-rg-T22839-Ab-2Anti-Rat CELA1 monoclonal antibodyRat
GM-Tg-mg-T22839-Ab-1/ GM-Tg-mg-T22839-Ab-2Anti-Mouse CELA1 monoclonal antibodyMouse
GM-Tg-cynog-T22839-Ab-1/ GM-Tg-cynog-T22839-Ab-2Anti-Cynomolgus/ Rhesus macaque CELA1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T22839-Ab-1/ GM-Tg-felg-T22839-Ab-2Anti-Feline CELA1 monoclonal antibodyFeline
GM-Tg-cang-T22839-Ab-1/ GM-Tg-cang-T22839-Ab-2Anti-Canine CELA1 monoclonal antibodyCanine
GM-Tg-bovg-T22839-Ab-1/ GM-Tg-bovg-T22839-Ab-2Anti-Bovine CELA1 monoclonal antibodyBovine
GM-Tg-equg-T22839-Ab-1/ GM-Tg-equg-T22839-Ab-2Anti-Equine CELA1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T22839-Ab-1/ GM-Tg-hg-T22839-Ab-2; GM-Tg-rg-T22839-Ab-1/ GM-Tg-rg-T22839-Ab-2;
GM-Tg-mg-T22839-Ab-1/ GM-Tg-mg-T22839-Ab-2; GM-Tg-cynog-T22839-Ab-1/ GM-Tg-cynog-T22839-Ab-2;
GM-Tg-felg-T22839-Ab-1/ GM-Tg-felg-T22839-Ab-2; GM-Tg-cang-T22839-Ab-1/ GM-Tg-cang-T22839-Ab-2;
GM-Tg-bovg-T22839-Ab-1/ GM-Tg-bovg-T22839-Ab-2; GM-Tg-equg-T22839-Ab-1/ GM-Tg-equg-T22839-Ab-2
Products NameAnti-CELA1 monoclonal antibody
Formatmab
Target NameCELA1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CELA1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T22839-Ag-1Recombinant multi-species CELA1/ ELA1 protein


    Target information

    Target IDGM-T22839
    Target NameCELA1
    Gene ID1990,109901,24331,695507,494217,281139,100052672
    Gene Symbol and Synonyms1810009A17Rik,1810062B19Rik,CELA1,Ela-1,ELA1,ELAI1,ELS1,PC-TsF,RATELAI1
    Uniprot AccessionQ9UNI1,P00773,Q5R1M5,Q28153
    Uniprot Entry NameCELA1_HUMAN,CELA1_RAT,CELA1_FELCA,CELA1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000139610
    Target ClassificationN/A

    The target: CELA1, gene name: CELA1, also named as ELA1. Elastases form a subfamily of serine proteases that hydrolyze many proteins in addition to elastin. Humans have six elastase genes which encode the structurally similar proteins elastase 1, 2, 2A, 2B, 3A, and 3B. Unlike other elastases, pancreatic elastase 1 is not expressed in the pancreas. To date, elastase 1 expression has only been detected in skin keratinocytes. Clinical literature that describes human elastase 1 activity in the pancreas or fecal material is actually referring to chymotrypsin-like elastase family, member 3B. [provided by RefSeq, May 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.